Tech Oligarchs and the Rise of Silicon Valley Pronatalism
By Maren Behrensen,
Tech Policy Press
| 07. 02. 2025
Why is it dangerous when corporate executives, entrepreneurs and investors with enormous wealth and power collectively control the development and deployment of our most pervasive technologies? Most answers to this question focus on the technologies themselves, or the ways in which the interests of these individuals, with their vast wealth and influence, are counter to the interests of democracy. Most Tech Policy Press readers are well aware that their social media platforms shape opinions, their money buys elections, and their AI models seem poised to dominate the economy.
But among a certain subset of Silicon Valley elites, a stranger set of ideas has emerged in recent years that corresponds to much more significant ambitions to reshape society than merely to propagate artificial intelligence across every aspect of life and work or to subjugate governments to corporate power. Understanding these ideas and their implications is important to resisting the power and influence of these individuals.
One of these ideas is pronatalism. Connected to the political, economic, and technological visions held by a number of billionaire tech oligarchs, the Silicon Valley strain...
Related Articles
By Jackie Davalos, Bloomberg | 09.15.2025
Kindbody, one of the largest fertility companies in the US, sought to disrupt egg freezing and IVF by combining spa vibes with Silicon Valley efficiency. The startup raised millions, opened dozens of clinics, and became a billion-dollar unicorn. But its...
By Holly Baxter, The Independent | 08.19.2025
In rural Pennsylvania, I’m hiking through the forest with Simone and Malcom Collins and discussing the executive order they wrote for Donald Trump. Just outside their house — beyond the chicken coop, where they gather their eggs for homemade cakes...
By Grace Tobin and Kirsten Robb, ABC News Australia | 09.01.2025
A secret audit of a major fertility clinic revealed that almost all of its donor sperm being provided to patients was at high risk of potential mix-ups.
The Queensland Fertility Group (QFG), which is owned by Australia's largest IVF company...
By Tia Ghose, Live Science | 09.16.2025
Twenty-six years ago today, on Sept. 17, a teenager who had received an experimental gene therapy died. His death led to needed changes in the clinical trial process while also spurring skepticism that would ultimately stall the field of gene...